Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Speech disturbance at stroke onset is correlated with stroke early mortality.
Shigematsu K, Nakano H, Watanabe Y, Sekimoto T, Shimizu K, Nishizawa A, Okumura A, Makino M. Shigematsu K, et al. Among authors: nishizawa a. BMC Neurol. 2013 Jul 15;13:87. doi: 10.1186/1471-2377-13-87. BMC Neurol. 2013. PMID: 23855651 Free PMC article.
BACKGROUND: Speech disturbance is a common symptom of stroke and is important as a prompt identifier of the event. ...Hazard ratio for death was higher in stroke patients with speech disturbance than patients without. Speech disturbance is a prompt predictor …
BACKGROUND: Speech disturbance is a common symptom of stroke and is important as a prompt identifier of the event. ...Hazard r …
Vomiting should be a prompt predictor of stroke outcome.
Shigematsu K, Shimamura O, Nakano H, Watanabe Y, Sekimoto T, Shimizu K, Nishizawa A, Makino M. Shigematsu K, et al. Among authors: nishizawa a. Emerg Med J. 2013 Sep;30(9):728-31. doi: 10.1136/emermed-2012-201586. Epub 2012 Sep 27. Emerg Med J. 2013. PMID: 23018288
Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study.
Uozumi S, Enokida T, Suzuki S, Nishizawa A, Kamata H, Okano T, Kawasaki T, Fujisawa T, Ueda Y, Okano S, Tahara M, Yamaguchi M. Uozumi S, et al. Among authors: nishizawa a. J Oncol Pharm Pract. 2024 Mar;30(2):295-303. doi: 10.1177/10781552231171699. Epub 2023 Apr 25. J Oncol Pharm Pract. 2024. PMID: 37098185
154 results